drugset / Trial / NCT00012129

Chemotherapy in Treating Patients With Breast Cancer

NCT00012129 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of annamycin liposomal in treating patients who have locally advanced or metastatic breast cancer that has not responded to previous chemotherapy.

Timeline

Start
1998-09
Primary completion
2001-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject NAXTARUBICIN Small molecule — Intravenous

Indications